These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1750793)

  • 21. Case management of the anemic patient. Epoetin alfa: focus on iron management.
    Kirlin LF
    ANNA J; 1990 Jun; 17(3):256-7. PubMed ID: 2357123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Case management of the anemic patient: epoetin alfa--focus on ventricular function.
    Schardin KE
    ANNA J; 1993 Feb; 20(1):96-9. PubMed ID: 8431032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant human erythropoietin correction of anemia. Dialysis efficiency, waste retention, and chronic dose variables.
    Paganini EP; Abdulhadi MH; Garcia J; Magnusson MO
    ASAIO Trans; 1989; 35(3):513-5. PubMed ID: 2688718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Case management of the anemic patient. Epoetin alfa: focus on patient teaching.
    Sasak C; Giordano E
    ANNA J; 1990 Apr; 17(2):188-9. PubMed ID: 2327804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anemia management of adult hemodialysis patients in the US results: from the 1997 ESRD Core Indicators Project.
    Frankenfield D; Johnson CA; Wish JB; Rocco MV; Madore F; Owen WF
    Kidney Int; 2000 Feb; 57(2):578-89. PubMed ID: 10652035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Case management of the anemic patient. Focus on hemodynamics.
    Pugh M; Saylor G
    ANNA J; 1991 Jun; 18(3):316-7. PubMed ID: 2064457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Case management of the anemic patient. Epoetin alfa: focus on nutrition management.
    Hensley MK
    ANNA J; 1990 Oct; 17(5):390-1. PubMed ID: 2241257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epoetin alfa: patient management issues and development through recombinant DNA technology. Part 1: Focus on Epoetin alfa patient management and recombinant DNA technology.
    Latham D; Nichols E
    ANNA J; 1990 Aug; 17(4):311-4. PubMed ID: 2396857
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anemia management protocols and epoetin alfa administration: an algorithm approach. Case study of the anemic patient.
    Aiello J
    Nephrol Nurs J; 2002 Jun; 29(3):297-300. PubMed ID: 12164081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dialysis patients treated with Epoetin alfa show improved anemia symptoms: A new analysis of the Canadian Erythropoietin Study Group trial.
    Keown PA; Churchill DN; Poulin-Costello M; Lei L; Gantotti S; Agodoa I; Gitlin M; Gandra SR; Mayne TJ
    Hemodial Int; 2010 Apr; 14(2):168-73. PubMed ID: 20345390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the therapeutic effects of epoetin zeta to epoetin alfa in the maintenance phase of renal anaemia treatment.
    Wizemann V; Rutkowski B; Baldamus C; Scigalla P; Koytchev R;
    Curr Med Res Opin; 2008 Mar; 24(3):625-37. PubMed ID: 18208642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Case study of the anemic patient: epoetin alfa--focus on CQI and patient management.
    Kammerer JK
    ANNA J; 1994 Aug; 21(5):282-5. PubMed ID: 8080342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epoetin alfa: focus on inflammation and infection. Case study of the anemic patient.
    Chambers JK
    ANNA J; 1998 Jun; 25(3):353-6. PubMed ID: 9801493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Switching epoetin alfa and epoetin zeta in patients with renal anemia on dialysis: Posthoc analysis.
    Więcek A; Ahmed I; Scigalla P; Koytchev R
    Adv Ther; 2010 Dec; 27(12):941-52. PubMed ID: 20972656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epoetin alfa: clinical trial therapy.
    ANNA J; 1989 Aug; 16(5):344-8. PubMed ID: 2673077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nursing care of predialysis patients receiving epoetin alfa.
    Brown JM
    ANNA J; 1991 Jun; 18(3):306-14. PubMed ID: 2064456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Timely correction of anemia at the initiation of dialysis. Case study of the anemic patient.
    Breiterman-White R
    Nephrol Nurs J; 2002 Oct; 29(5):469-72. PubMed ID: 12434453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of the chronic renal failure patient receiving epoetin alfa for the treatment of anemia.
    Binkley LS
    Transplant Proc; 1991 Apr; 23(2):1831-2. PubMed ID: 2053169
    [No Abstract]   [Full Text] [Related]  

  • 39. Epoetin alfa--focus on the rehabilitation of dialysis patients. Case study of the anemic patient.
    Martin-Lester M
    ANNA J; 1996 Dec; 23(6):630-3. PubMed ID: 9069794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epoetin requirement does not depend on dialysis dose when Kt/N > 1.33 in patients on regular dialysis treatment with cellulosic membranes and adequate iron stores.
    Movilli E; Cancarini GC; Vizzardi V; Camerini C; Brunori G; Cassamali S; Maiorca R
    J Nephrol; 2003; 16(4):546-51. PubMed ID: 14696757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.